Coloplast saw the highest growth of 2.99% in patent filings in April and 2.08% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 2.99% and grants by 0.6%. GlobalData’s DataBook provides a comprehensive analysis of Coloplast’s patent filings and grants. Buy the databook here.
Coloplast has been focused on protecting inventions in European Patent Office(EPO) with 37 publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 33% filings and 52% grants. The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and Australia(AU) patent Office are among the top ten patent offices where Coloplast is filings its patents. Among the top granted patent authorities, Coloplast has 52% of its grants in European Patent Office(EPO), 26% in United States(US) and 15% in Australia(AU).
Ostomycure could be the strongest competitor for Coloplast
Patents related to healthtech and connected patient lead Coloplast's portfolio
Coloplast has the highest number of patents in healthtech followed by, connected patient and remote patient monitoring. For healthtech, nearly 35% of patents were filed and 31% of patents were granted in Q2 2024.
Nephrology and urology devices related patents lead Coloplast portfolio followed by other remote patient monitoring, and healthcare it
Coloplast has highest number of patents in nephrology and urology devices followed by other remote patient monitoring, healthcare it, first aid and wound care, and orthopedic devices. For nephrology and urology devices, nearly 21% of patents were filed and 23% of patents were granted in Q2 2024.
For comprehensive analysis of Coloplast's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.